Cargando…

Comparison of patients hospitalized with COVID-19, H7N9 and H1N1

BACKGROUND: There is an urgent need to better understand the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), for that the coronavirus disease 2019 (COVID-19) continues to cause considerable morbidity and mortality worldwide. This paper was to differentiate COVID-19 f...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Li-Si, Yuan, Jing, Ding, Li, Chen, Yuan-Li, Zhao, Chao-Hui, Chen, Gong-Qi, Li, Xing-Hua, Li, Xiao-He, Luo, Wen-Tao, Lan, Jian-Feng, Tan, Guo-Yu, Tang, Sheng-Hong, Xia, Jin-Yu, Liu, Xi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707904/
https://www.ncbi.nlm.nih.gov/pubmed/33261654
http://dx.doi.org/10.1186/s40249-020-00781-5
_version_ 1783617452231360512
author Deng, Li-Si
Yuan, Jing
Ding, Li
Chen, Yuan-Li
Zhao, Chao-Hui
Chen, Gong-Qi
Li, Xing-Hua
Li, Xiao-He
Luo, Wen-Tao
Lan, Jian-Feng
Tan, Guo-Yu
Tang, Sheng-Hong
Xia, Jin-Yu
Liu, Xi
author_facet Deng, Li-Si
Yuan, Jing
Ding, Li
Chen, Yuan-Li
Zhao, Chao-Hui
Chen, Gong-Qi
Li, Xing-Hua
Li, Xiao-He
Luo, Wen-Tao
Lan, Jian-Feng
Tan, Guo-Yu
Tang, Sheng-Hong
Xia, Jin-Yu
Liu, Xi
author_sort Deng, Li-Si
collection PubMed
description BACKGROUND: There is an urgent need to better understand the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), for that the coronavirus disease 2019 (COVID-19) continues to cause considerable morbidity and mortality worldwide. This paper was to differentiate COVID-19 from other respiratory infectious diseases such as avian-origin influenza A (H7N9) and influenza A (H1N1) virus infections. METHODS: We included patients who had been hospitalized with laboratory-confirmed infection by SARS-CoV-2 (n = 83), H7N9 (n = 36), H1N1 (n = 44) viruses. Clinical presentation, chest CT features, and progression of patients were compared. We used the Logistic regression model to explore the possible risk factors. RESULTS: Both COVID-19 and H7N9 patients had a longer duration of hospitalization than H1N1 patients (P < 0.01), a higher complication rate, and more severe cases than H1N1 patients. H7N9 patients had higher hospitalization-fatality ratio than COVID-19 patients (P = 0.01). H7N9 patients had similar patterns of lymphopenia, neutrophilia, elevated alanine aminotransferase, C-reactive protein, lactate dehydrogenase, and those seen in H1N1 patients, which were all significantly different from patients with COVID-19 (P < 0.01). Either H7N9 or H1N1 patients had more obvious symptoms, like fever, fatigue, yellow sputum, and myalgia than COVID-19 patients (P < 0.01). The mean duration of viral shedding was 9.5 days for SARS-CoV-2 vs 9.9 days for H7N9 (P = 0.78). For severe cases, the meantime from illness onset to severity was 8.0 days for COVID-19 vs 5.2 days for H7N9 (P < 0.01), the comorbidity of chronic heart disease was more common in the COVID-19 patients than H7N9 (P = 0.02). Multivariate analysis showed that chronic heart disease was a possible risk factor (OR > 1) for COVID-19, compared with H1N1 and H7N9. CONCLUSIONS: The proportion of severe cases were higher for H7N9 and SARS-CoV-2 infections, compared with H1N1. The meantime from illness onset to severity was shorter for H7N9. Chronic heart disease was a possible risk factor for COVID-19.The comparison may provide the rationale for strategies of isolation and treatment of infected patients in the future.
format Online
Article
Text
id pubmed-7707904
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-77079042020-12-02 Comparison of patients hospitalized with COVID-19, H7N9 and H1N1 Deng, Li-Si Yuan, Jing Ding, Li Chen, Yuan-Li Zhao, Chao-Hui Chen, Gong-Qi Li, Xing-Hua Li, Xiao-He Luo, Wen-Tao Lan, Jian-Feng Tan, Guo-Yu Tang, Sheng-Hong Xia, Jin-Yu Liu, Xi Infect Dis Poverty Research Article BACKGROUND: There is an urgent need to better understand the novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), for that the coronavirus disease 2019 (COVID-19) continues to cause considerable morbidity and mortality worldwide. This paper was to differentiate COVID-19 from other respiratory infectious diseases such as avian-origin influenza A (H7N9) and influenza A (H1N1) virus infections. METHODS: We included patients who had been hospitalized with laboratory-confirmed infection by SARS-CoV-2 (n = 83), H7N9 (n = 36), H1N1 (n = 44) viruses. Clinical presentation, chest CT features, and progression of patients were compared. We used the Logistic regression model to explore the possible risk factors. RESULTS: Both COVID-19 and H7N9 patients had a longer duration of hospitalization than H1N1 patients (P < 0.01), a higher complication rate, and more severe cases than H1N1 patients. H7N9 patients had higher hospitalization-fatality ratio than COVID-19 patients (P = 0.01). H7N9 patients had similar patterns of lymphopenia, neutrophilia, elevated alanine aminotransferase, C-reactive protein, lactate dehydrogenase, and those seen in H1N1 patients, which were all significantly different from patients with COVID-19 (P < 0.01). Either H7N9 or H1N1 patients had more obvious symptoms, like fever, fatigue, yellow sputum, and myalgia than COVID-19 patients (P < 0.01). The mean duration of viral shedding was 9.5 days for SARS-CoV-2 vs 9.9 days for H7N9 (P = 0.78). For severe cases, the meantime from illness onset to severity was 8.0 days for COVID-19 vs 5.2 days for H7N9 (P < 0.01), the comorbidity of chronic heart disease was more common in the COVID-19 patients than H7N9 (P = 0.02). Multivariate analysis showed that chronic heart disease was a possible risk factor (OR > 1) for COVID-19, compared with H1N1 and H7N9. CONCLUSIONS: The proportion of severe cases were higher for H7N9 and SARS-CoV-2 infections, compared with H1N1. The meantime from illness onset to severity was shorter for H7N9. Chronic heart disease was a possible risk factor for COVID-19.The comparison may provide the rationale for strategies of isolation and treatment of infected patients in the future. BioMed Central 2020-12-02 /pmc/articles/PMC7707904/ /pubmed/33261654 http://dx.doi.org/10.1186/s40249-020-00781-5 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Deng, Li-Si
Yuan, Jing
Ding, Li
Chen, Yuan-Li
Zhao, Chao-Hui
Chen, Gong-Qi
Li, Xing-Hua
Li, Xiao-He
Luo, Wen-Tao
Lan, Jian-Feng
Tan, Guo-Yu
Tang, Sheng-Hong
Xia, Jin-Yu
Liu, Xi
Comparison of patients hospitalized with COVID-19, H7N9 and H1N1
title Comparison of patients hospitalized with COVID-19, H7N9 and H1N1
title_full Comparison of patients hospitalized with COVID-19, H7N9 and H1N1
title_fullStr Comparison of patients hospitalized with COVID-19, H7N9 and H1N1
title_full_unstemmed Comparison of patients hospitalized with COVID-19, H7N9 and H1N1
title_short Comparison of patients hospitalized with COVID-19, H7N9 and H1N1
title_sort comparison of patients hospitalized with covid-19, h7n9 and h1n1
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7707904/
https://www.ncbi.nlm.nih.gov/pubmed/33261654
http://dx.doi.org/10.1186/s40249-020-00781-5
work_keys_str_mv AT denglisi comparisonofpatientshospitalizedwithcovid19h7n9andh1n1
AT yuanjing comparisonofpatientshospitalizedwithcovid19h7n9andh1n1
AT dingli comparisonofpatientshospitalizedwithcovid19h7n9andh1n1
AT chenyuanli comparisonofpatientshospitalizedwithcovid19h7n9andh1n1
AT zhaochaohui comparisonofpatientshospitalizedwithcovid19h7n9andh1n1
AT chengongqi comparisonofpatientshospitalizedwithcovid19h7n9andh1n1
AT lixinghua comparisonofpatientshospitalizedwithcovid19h7n9andh1n1
AT lixiaohe comparisonofpatientshospitalizedwithcovid19h7n9andh1n1
AT luowentao comparisonofpatientshospitalizedwithcovid19h7n9andh1n1
AT lanjianfeng comparisonofpatientshospitalizedwithcovid19h7n9andh1n1
AT tanguoyu comparisonofpatientshospitalizedwithcovid19h7n9andh1n1
AT tangshenghong comparisonofpatientshospitalizedwithcovid19h7n9andh1n1
AT xiajinyu comparisonofpatientshospitalizedwithcovid19h7n9andh1n1
AT liuxi comparisonofpatientshospitalizedwithcovid19h7n9andh1n1